FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4380360479> ?p ?o ?g. }

• W4380360479 endingPage "336" @default.
• W4380360479 startingPage "326" @default.
• W4380360479 abstract "In the last decade, a deeper understanding of the pathogenesis of complement mediated hemolytic disorders, such as paroxysmal nocturnal hemoglobinuria (PNH), cold agglutinin disease (CAD), warm type autoimmune hemolytic anemia (AIHA) with complement activation (wAIHA), and atypical hemolytic uremic syndrome (aHUS), paved the way to the therapeutic shift from purely supportive approaches to complement-targeted therapies. This resulted in a significant improvement in disease management, survival, and quality of life. In this review, we will provide a snapshot of novel therapies for complement-mediated hemolytic anemias with a focus on those ready to use in clinical practice. C5 inhibitors eculizumab and the long-acting ravulizumab, are the established gold standard for untreated PNH patients, whilst the C3 inhibitor pegcetacoplan should be considered for suboptimal responders to anti-C5 drugs. Several additional compounds targeting the complement cascade at different levels (other C5 inhibitors, factor B and D inhibitors) are under active investigation with promising results. In CAD, immunosuppression with rituximab remains the first-line. However, recently FDA and EMA approved the anti-C1s monoclonal antibody, sutimlimab, that showed dramatic responses and whose regulatory approval is soon awaited in many countries. Other drugs under investigation in AIHA include the C3 inhibitor pegcetacoplan, and the anti-C1q ANX005 for warm AIHA with complement activation. Finally, aHUS is an indication for complement inhibitors. Eculizumab and ravulizumab have been approved, whilst other C5 inhibitors, and novel lectin pathway inhibitors are under active investigation in this disease." @default.
• W4380360479 created "2023-06-13" @default.
• W4380360479 creator A5008952684 @default.
• W4380360479 creator A5034535532 @default.
• W4380360479 creator A5076368199 @default.
• W4380360479 date "2023-06-12" @default.
• W4380360479 modified "2023-10-01" @default.
• W4380360479 title "Molecular pharmacology in complement‐mediated hemolytic disorders" @default.
• W4380360479 cites W119432673 @default.
• W4380360479 cites W1990583508 @default.
• W4380360479 cites W1991463908 @default.
• W4380360479 cites W2004265876 @default.
• W4380360479 cites W2031215908 @default.
• W4380360479 cites W2102516979 @default.
• W4380360479 cites W2105749209 @default.
• W4380360479 cites W2106675927 @default.
• W4380360479 cites W2118510193 @default.
• W4380360479 cites W2123753762 @default.
• W4380360479 cites W2126092981 @default.
• W4380360479 cites W2148110062 @default.
• W4380360479 cites W2152757679 @default.
• W4380360479 cites W2335653426 @default.
• W4380360479 cites W2495862253 @default.
• W4380360479 cites W2559649218 @default.
• W4380360479 cites W2623395391 @default.
• W4380360479 cites W2751882444 @default.
• W4380360479 cites W2784858290 @default.
• W4380360479 cites W2791374135 @default.
• W4380360479 cites W2797057269 @default.
• W4380360479 cites W2880269136 @default.
• W4380360479 cites W2888329264 @default.
• W4380360479 cites W2889540205 @default.
• W4380360479 cites W2951566892 @default.
• W4380360479 cites W2990518153 @default.
• W4380360479 cites W2994304950 @default.
• W4380360479 cites W3001593205 @default.
• W4380360479 cites W3009429865 @default.
• W4380360479 cites W3022726062 @default.
• W4380360479 cites W3022932600 @default.
• W4380360479 cites W3033059449 @default.
• W4380360479 cites W3042589753 @default.
• W4380360479 cites W3049300697 @default.
• W4380360479 cites W3097686946 @default.
• W4380360479 cites W3106779259 @default.
• W4380360479 cites W3108107578 @default.
• W4380360479 cites W3124525339 @default.
• W4380360479 cites W3124977663 @default.
• W4380360479 cites W3125495858 @default.
• W4380360479 cites W3134680917 @default.
• W4380360479 cites W3136167138 @default.
• W4380360479 cites W3144481484 @default.
• W4380360479 cites W3183565120 @default.
• W4380360479 cites W3186910440 @default.
• W4380360479 cites W3202358903 @default.
• W4380360479 cites W3204455148 @default.
• W4380360479 cites W3213901885 @default.
• W4380360479 cites W3214474180 @default.
• W4380360479 cites W3216374510 @default.
• W4380360479 cites W4221033144 @default.
• W4380360479 cites W4242833177 @default.
• W4380360479 cites W4249789249 @default.
• W4380360479 cites W4280534946 @default.
• W4380360479 cites W4281636030 @default.
• W4380360479 cites W4282937282 @default.
• W4380360479 cites W4283368186 @default.
• W4380360479 cites W4283372524 @default.
• W4380360479 cites W4285114509 @default.
• W4380360479 cites W4285387233 @default.
• W4380360479 cites W4294770709 @default.
• W4380360479 cites W4309280962 @default.
• W4380360479 doi "https://doi.org/10.1111/ejh.14026" @default.
• W4380360479 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37308291" @default.
• W4380360479 hasPublicationYear "2023" @default.
• W4380360479 type Work @default.
• W4380360479 citedByCount "1" @default.
• W4380360479 countsByYear W43803604792023 @default.
• W4380360479 crossrefType "journal-article" @default.
• W4380360479 hasAuthorship W4380360479A5008952684 @default.
• W4380360479 hasAuthorship W4380360479A5034535532 @default.
• W4380360479 hasAuthorship W4380360479A5076368199 @default.
• W4380360479 hasBestOaLocation W43803604791 @default.
• W4380360479 hasConcept C111684460 @default.
• W4380360479 hasConcept C159654299 @default.
• W4380360479 hasConcept C189446657 @default.
• W4380360479 hasConcept C203014093 @default.
• W4380360479 hasConcept C203880312 @default.
• W4380360479 hasConcept C2776175824 @default.
• W4380360479 hasConcept C2777346216 @default.
• W4380360479 hasConcept C2777385706 @default.
• W4380360479 hasConcept C2777637130 @default.
• W4380360479 hasConcept C2777884830 @default.
• W4380360479 hasConcept C2777991916 @default.
• W4380360479 hasConcept C2780653079 @default.
• W4380360479 hasConcept C71924100 @default.
• W4380360479 hasConceptScore W4380360479C111684460 @default.
• W4380360479 hasConceptScore W4380360479C159654299 @default.
• W4380360479 hasConceptScore W4380360479C189446657 @default.
• W4380360479 hasConceptScore W4380360479C203014093 @default.

• next